Since the Dow is within spitting distance of breaking the 20,000 point level, for the first time, let’s look at what the pros are thinking. Jim Suva, Citi Research Analyst, forecast a “Tax reform benefit from reduction in corporate taxes and cash repatriation,” as Citi Research reiterated its buy rating on Apple (NASDAQ: AAPL), while CNBC’s Jim Cramer added that IBM (NYSE: IBM) “would be a huge beneficiary of Trump’s proposed lower corporate tax rates. It is a terrific play on a stronger economy.” So, it’s looking like the experts think that the Dow stalwarts are going to benefit from a slew of business friendly moves, but the iShares Russell 2000 ETF (NYSE: IWM) is also near all-time highs, so it’s not just the big boys in play.
As a leading provider of automated digital platform technology and social management software for Internet and mobile advertising, Social Reality (NASDAQ: SRAX) is well positioned to benefit from many of the same dynamics as the large caps. In fact, since the company’s advanced ad serving technology and seamless integration can now empower its clients to build and run a vertical ad network, there’s a strong argument for Social Reality directly benefiting from the improved bottom lines of other companies, as some companies should be seeking to more aggressively expand their marketing efforts.
Suva further stated, in a note to clients, that Apple shares can march to $130 for other reasons including, “Sticky user base which drives continued services revenue growth” and “Attractive valuation – Shares trade at a slight discount to their 4 year median multiples despite improving fundamentals ahead,” but lowering the U.S. corporate tax rate would increase Apple’s bottom line and “we see Apple as a significant beneficiary of Trump tax reforms. Apple is very well positioned to benefit from potential tax reform of either or both a repatriation tax holiday and or a lower corporate tax rate.”
Cramer sees that the big caps are in play, but IBM is one that tickles his fancy because, despite the fact that IBM is performing in the top 20% of Dow listings for the year, it’s still 50 points below where it was priced four years ago. Yet, at merely 12 times earnings, it’s one of the most attractive listings in the Dow, on an EPS basis. Plus, as IBM continues to grow its cloud business, there’s an even wider gap between its pricing in relative terms to its peers.
Management has consistently grown Social Reality’s revenues, from about $500,000 in 2010 to over $30 million in 2015, an average annual growth rate (AAGR) of 170%, while typically running blended gross margins in the 45-55% range.
Social Reality appointed Kathy Ireland as a chief branding advisor to help the company identify top industry executives in the media, entertainment and advertising industries for building out an Advisory Board. In June 2016, Ireland was ranked by Forbes as one of the 60 richest self-made women in America and kathy ireland® Worldwide brand is listed as the 25th most powerful brand globally, by License Global Magazine, reporting worldwide sales in excess of $2.5 billion in 2012.
The company uplisted to the NASDAQ Capital Market in October 2016, with both analysts calling it a buy, on an EPS of 27 cents in 2017 with an average price target of $10.75.
For more Social Reality information, please visit www.socialreality.com www.srax.com www.sraxmd.com www.sraxdi.com www.groupad.com www.steelmediainc.com www.sraxsocial.com
About Stock Communications Group (SCG)
Stock Communications Group (SCG) specializes in providing superior capital market communications. Our team of experienced tactical specialists can benefit public and private companies with proven financial strategies and solutions. Our investor relations and public relations services ensure that your company effectively communicates with investors, shareholders, regulators, and the financial community; to ensure that your company’s message properly promotes your company’s image, protects your brand, and maximizes your valuation.
SCG specializes in creating objective, credible, and timely communications that’s convenient and easy to understand. From conference call and annual meeting webcasts to creating special investor relations websites, we do it all. We even handle direct response duties to inquiries from individual investors, corporate profiles and other supporting publications, news releases and subscriber services. Our success stories span all industry sectors and are at the ready to deploy our unique resources to make your efforts truly successful.
SCG Disclosure: www.stockcommgroup.com has been actively profiling public companies since 1999 bringing our readers timely and valuable market information first. Nothing in our reports or on our site should constitute a recommendation to buy or sell any stock. We will not be buying, selling or trading in any of the above listed stocks during the publication of this report. SCG has been compensated by MarketStreet for this article. Investors should conduct their own due diligence and consult with a stock broker or investment advisor before making any investment decision. Some of our statements are our opinion and should be taken as such, and this release contains Forward Looking statements as well.
Read our full disclosure at www.stockcommgroup.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
Thursday, December 15, 2016
Hope for HIV Patients as Cytodyn Inc. (CYDY) Therapy Proves Efficacy during Clinical Trials
PRO 140, an innovative new therapy for HIV patients developed by Cytodyn, Inc. (OTCQB: CYDY), is currently undergoing phase 3 clinical trials, having been administered to several patients, according to a company press release (http://nnw.fm/a8eyJ). No other details were provided about the initial results of phase 3 trials, but a separate report said actor Charlie Sheen is one of the subjects and that he has achieved undetectable viral load after taking PRO 140.
Sheen, who revealed his HIV status in November last year, has been a part of the study for eight months and is receiving weekly injections of the drug, the report said. The phase 3 study is looking into PRO 140’s safety and effectiveness in HIV patients and is being administered without any other HIV medication to determine whether it alone is enough to fight HIV and help subjects achieve an undetectable viral load.
Cytodyn, a biotech company that focuses on the development of innovative antibody therapies against the human immunodeficiency virus and other diseases, has not officially commented on the Daily Mail report. In a press release this week, however, it announced that several patients have already been treated with PRO 140 as part of the phase 3, multicenter clinical trial which will enroll a total of 300 subjects. All the patients included in the study have CCR5-tropic HIV-1 infection and are clinically stable, being on highly active antiretroviral therapy up to one week after the enrollment.
During the phase 3 trial, the subjects will receive only PRO 140 in the form of subcutaneous injections for 48 weeks to determine whether the product candidate is safe and efficient as a single-agent maintenance therapy for chronic suppression of HIV. PRO 140 is a fully humanized monoclonal antibody that specifically targets the CCR5 entry receptor on CD4 cells, which HIV targets and takes over. The proprietary therapy fights HIV by blocking this entry point and preventing the virus from infecting healthy cells.
CytoDyn CEO and President Nader Pourhassan, Ph.D. said his company expects the monotherapy trial to yield significant results and provide sufficient data to support further clinical and regulatory advancement of the treatment. He explained that the phase 3 trial is nearly a duplicate of the phase 2b trial that ended last year, with an additional objective of determining why some R5 patients are not responding to the therapy as well as others. Out of 15 subjects who continued the trial in the extension arm and received weekly PRO 140 injections in phase 2b trials, 10 maintained an undetectable viral load for more than two years, while four others did not report any changes in their HIV infection. The last patient moved away and could not be monitored.
Pourhassan is confident that the phase 3 trial findings will help determine which patients can achieve long-term HIV suppression and ultimately secure label expansion for PRO 140 as a single agent therapy, given it has low toxicity and virtually no side effects. PRO 140 only targets HIV patients with the R5 strain, Pourhassan added. This strain currently accounts for about 70 percent of HIV infections and 90 percent of newly-diagnosed cases in the United States.
For more information, visit www.cytodyn.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
Sheen, who revealed his HIV status in November last year, has been a part of the study for eight months and is receiving weekly injections of the drug, the report said. The phase 3 study is looking into PRO 140’s safety and effectiveness in HIV patients and is being administered without any other HIV medication to determine whether it alone is enough to fight HIV and help subjects achieve an undetectable viral load.
Cytodyn, a biotech company that focuses on the development of innovative antibody therapies against the human immunodeficiency virus and other diseases, has not officially commented on the Daily Mail report. In a press release this week, however, it announced that several patients have already been treated with PRO 140 as part of the phase 3, multicenter clinical trial which will enroll a total of 300 subjects. All the patients included in the study have CCR5-tropic HIV-1 infection and are clinically stable, being on highly active antiretroviral therapy up to one week after the enrollment.
During the phase 3 trial, the subjects will receive only PRO 140 in the form of subcutaneous injections for 48 weeks to determine whether the product candidate is safe and efficient as a single-agent maintenance therapy for chronic suppression of HIV. PRO 140 is a fully humanized monoclonal antibody that specifically targets the CCR5 entry receptor on CD4 cells, which HIV targets and takes over. The proprietary therapy fights HIV by blocking this entry point and preventing the virus from infecting healthy cells.
CytoDyn CEO and President Nader Pourhassan, Ph.D. said his company expects the monotherapy trial to yield significant results and provide sufficient data to support further clinical and regulatory advancement of the treatment. He explained that the phase 3 trial is nearly a duplicate of the phase 2b trial that ended last year, with an additional objective of determining why some R5 patients are not responding to the therapy as well as others. Out of 15 subjects who continued the trial in the extension arm and received weekly PRO 140 injections in phase 2b trials, 10 maintained an undetectable viral load for more than two years, while four others did not report any changes in their HIV infection. The last patient moved away and could not be monitored.
Pourhassan is confident that the phase 3 trial findings will help determine which patients can achieve long-term HIV suppression and ultimately secure label expansion for PRO 140 as a single agent therapy, given it has low toxicity and virtually no side effects. PRO 140 only targets HIV patients with the R5 strain, Pourhassan added. This strain currently accounts for about 70 percent of HIV infections and 90 percent of newly-diagnosed cases in the United States.
For more information, visit www.cytodyn.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
Wednesday, December 14, 2016
As Social Reality (NASDAQ: SRAX) Completes “Pivotal Year” New White Paper Suggests Trend in Programmatic Growth
Social Reality, Inc. (NASDAQ: SRAX) is an Internet advertising company that has developed SRAX, a real-time bidding (RTB) management platform that, among other capabilities, increases the efficiency with which online publishers are able to capitalize on programmatic advertising auctions. In November, a new whitepaper (http://nnw.fm/m3LAi) sponsored by Xaxis, in conjunction with IDC, expanded upon the notion that programmatic technology is rapidly spreading and redefining the way many brands are approaching advertising. Based on the whitepaper’s findings, nearly $15 billion was spent on brand campaigns based on automated platforms during 2015, with IDC estimating in excess of $100 billion in spending on automated advertising by 2020. The whitepaper also found that currently 85% of U.S. buyers are using programmatic advertising in some form.
Programmatic advertising enables companies and brands to deliver highly targeted media to specific niche markets and demographics. A recent article (http://nnw.fm/oQin0) discussing real-time bidding as being at the core of where companies such as Facebook and Google have built their businesses states, “These technologies have created immense economic efficiencies. By tracking user behaviours, controlled for demographics, interests, locations and browsing history, these networks present data-driven solutions to the problem of identifying a target market.” The goal of this new media trend is to allow clients to reach prospective customers efficiently by identifying those who react positively to a product or service digitally and are the most likely to take action, thereby reducing marketing costs.
The Social Reality Ad Exchange (SRAX) platform makes it easier to optimize video, display, and mobile advertising on multiple platforms, and streamlines the process of launching and distributing targeted digital media campaigns. A transcription (http://nnw.fm/xe9fU) of a November 14 Q3 2016 earnings conference call quotes CEO Christopher Miglino as saying, “Those of you who closely follow our progress understand that this has been a pivotal year for Social Reality the first half of 2016 we launched and enhanced new products for our custom data management platforms. We tripled our sales team infrastructure as a result our third quarter revenues generated strong top-line growth of 29%, reflecting the strength of our business and our relentless focus on providing our clients with the most innovative and advertising tools.” The CEO also stated that, “Thus far we’ve been able to successfully achieve superior performance from our proprietary suite of products, which includes our solutions platform for programmatic buyers and sellers.”
The earnings conference call took place after a series of developments and strategic moves by the company the previous month, including its October 13 uplisting to the NASDAQ Capital Market. The following week saw the addition of two key experts; on October 18, Social Reality announced that business mogul Kathy Ireland would be joining as chief branding advisor, effective immediately; on October 20, the company announced (http://nnw.fm/7Bov2) that it had appointed financial and broadcasting veteran Joseph Patrick Hannan as CFO, effective October 17. Hannan most recently served as CFO of the second largest radio station operator in the U.S., Cumulus Media. Lastly, on November 3, the company announced it had enhanced the dynamic of its internet ad buy-and-sell solutions with the acquisition of Steel Media, a company with a 14-year track record in providing advertising inventory to top agencies and brands.
For more information, visit www.socialreality.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
Programmatic advertising enables companies and brands to deliver highly targeted media to specific niche markets and demographics. A recent article (http://nnw.fm/oQin0) discussing real-time bidding as being at the core of where companies such as Facebook and Google have built their businesses states, “These technologies have created immense economic efficiencies. By tracking user behaviours, controlled for demographics, interests, locations and browsing history, these networks present data-driven solutions to the problem of identifying a target market.” The goal of this new media trend is to allow clients to reach prospective customers efficiently by identifying those who react positively to a product or service digitally and are the most likely to take action, thereby reducing marketing costs.
The Social Reality Ad Exchange (SRAX) platform makes it easier to optimize video, display, and mobile advertising on multiple platforms, and streamlines the process of launching and distributing targeted digital media campaigns. A transcription (http://nnw.fm/xe9fU) of a November 14 Q3 2016 earnings conference call quotes CEO Christopher Miglino as saying, “Those of you who closely follow our progress understand that this has been a pivotal year for Social Reality the first half of 2016 we launched and enhanced new products for our custom data management platforms. We tripled our sales team infrastructure as a result our third quarter revenues generated strong top-line growth of 29%, reflecting the strength of our business and our relentless focus on providing our clients with the most innovative and advertising tools.” The CEO also stated that, “Thus far we’ve been able to successfully achieve superior performance from our proprietary suite of products, which includes our solutions platform for programmatic buyers and sellers.”
The earnings conference call took place after a series of developments and strategic moves by the company the previous month, including its October 13 uplisting to the NASDAQ Capital Market. The following week saw the addition of two key experts; on October 18, Social Reality announced that business mogul Kathy Ireland would be joining as chief branding advisor, effective immediately; on October 20, the company announced (http://nnw.fm/7Bov2) that it had appointed financial and broadcasting veteran Joseph Patrick Hannan as CFO, effective October 17. Hannan most recently served as CFO of the second largest radio station operator in the U.S., Cumulus Media. Lastly, on November 3, the company announced it had enhanced the dynamic of its internet ad buy-and-sell solutions with the acquisition of Steel Media, a company with a 14-year track record in providing advertising inventory to top agencies and brands.
For more information, visit www.socialreality.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
Moxian, Inc. (NASDAQ: MOXC) Embraces New Media for Interactive Marketing
Moxian, Inc. (NASDAQ: MOXC), a top digital marketing company, uses powerful social media-driven marketing and sales tools to connect online users and merchants. Backed by a flourishing online-to-offline integrated platform, this company offers offline merchants solid opportunities to strengthen their outreach to digital consumers.
Since it was founded in 2013, Moxian has catered to one particular business pain: the merchant’s need to engage with more digitally-savvy consumers. Along the way, this offline-to-online integrated platform operator has expanded from managing its operations from its base in Shenzhen, China, to creating branch offices in Beijing, Malaysia and Hong Kong.
Following the Nasdaq listing of its stock in November 2016 and the official launch of its Moxian+ App in recent months, Moxian is embarking on a new chapter. The company’s Moxian+ mobile application platform connects users to merchant clients through entertaining games, rewards and social events. In return, users provide valuable information that Moxian’s merchant clients can use to successfully market products and services sold at their brick and mortar stores.
From the start, Moxian has designed its products and services to allow merchant clients to run advertising campaigns and promotions targeting potential customers. Its platform was also developed and built to encourage current users to return frequently and to persuade new users to subscribe to its website. Now, Moxian is fully engaged in delivering products and services that compile user data into a comprehensive database, one that allows merchants to study and better understand user behavior and, in turn, improve their dealings with those users.
Over the years, Moxian has also moved beyond focusing on the domestic market in China to the global market as a whole. It has done so by establishing tactical data centers in both China and Singapore. At its data center in China, the company is leveraging the Oracle Exadata Database Machine in a private cloud environment in order to improve database computing, maximize database performance on the cloud platform and further save storage space and cost. And at its data center in Singapore, it is using the Oracle Database Appliance to boost database performance and lower overall investment cost with Flash, memory planning and other smart data technologies.
For more information, visit the company’s website at www.Moxian.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
Since it was founded in 2013, Moxian has catered to one particular business pain: the merchant’s need to engage with more digitally-savvy consumers. Along the way, this offline-to-online integrated platform operator has expanded from managing its operations from its base in Shenzhen, China, to creating branch offices in Beijing, Malaysia and Hong Kong.
Following the Nasdaq listing of its stock in November 2016 and the official launch of its Moxian+ App in recent months, Moxian is embarking on a new chapter. The company’s Moxian+ mobile application platform connects users to merchant clients through entertaining games, rewards and social events. In return, users provide valuable information that Moxian’s merchant clients can use to successfully market products and services sold at their brick and mortar stores.
From the start, Moxian has designed its products and services to allow merchant clients to run advertising campaigns and promotions targeting potential customers. Its platform was also developed and built to encourage current users to return frequently and to persuade new users to subscribe to its website. Now, Moxian is fully engaged in delivering products and services that compile user data into a comprehensive database, one that allows merchants to study and better understand user behavior and, in turn, improve their dealings with those users.
Over the years, Moxian has also moved beyond focusing on the domestic market in China to the global market as a whole. It has done so by establishing tactical data centers in both China and Singapore. At its data center in China, the company is leveraging the Oracle Exadata Database Machine in a private cloud environment in order to improve database computing, maximize database performance on the cloud platform and further save storage space and cost. And at its data center in Singapore, it is using the Oracle Database Appliance to boost database performance and lower overall investment cost with Flash, memory planning and other smart data technologies.
For more information, visit the company’s website at www.Moxian.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
Singlepoint, Inc. (SING) Maintaining a Positive Outlook on the Future of Marijuana Sales Processing
Despite California still looking to Trump to address marijuana industry banking challenges, Singlepoint, Inc. (OTC: SING) is maintaining a positive outlook on the future of marijuana sales processing in the state. An article by Above the Law (http://nnw.fm/1D0hL) suggests that California may be able to secure bank accounts relating to cannabis businesses as long as the FinCEN cannabis banking guidelines from 2014 hold up and certain enterprising financial institutions become more willing to experiment.
As a result of the passing of Proposition 64, many are confident that some of California’s financial institutions will be taking advantage of FinCEN’s 2014 guidelines by opening accounts for cannabis-related businesses. Despite there being worries of potential U.S. Attorney General, Jeff Sessions, or newly-elected President, Donald Trump, ordering the nullification of the Cole Memo, Trump has often stated that he believes these matters should be left to individual states to decide upon, a point brought forward during a recent interview with Singlepoint CEO Greg Lambrecht (http://nnw.fm/7GTHh).
Singlepoint is a holding company for a number of companies, including SingleSeed, an organization focused on providing efficient payment processing services to cannabis dispensaries in the U.S. The company started offering these services several years ago and intends to leverage its position as a ‘first mover’ in the marketplace after this year’s multi-state legalization of recreational marijuana.
During his interview on MoneyTV, Lambrecht shared the fact that the company has recently acquired the attention of a number of dispensaries interested in its services. According to the CEO, the company is redesigning the SingleSeed website in anticipation of the verdict on whether or not it will be able to aid cannabis businesses with their payment solutions moving forward. The company’s website revamp is expected to allow dispensaries to sign up in order for them to use a legal text message marketing program which will enable them to better communicate with their audiences.
This move will allow SingleSeed to start planning for the future, giving clients a head start and making the company a serious ‘first mover’ compared to competitors in the space. Although nothing is set in stone as to whether or not new laws will be put in place regarding the payment processing around the cannabis industry, Lambrecht stated that he believes decisions will be made as early as the first quarter of the coming year.
For more information, visit the company’s website at www.Singlepoint.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
As a result of the passing of Proposition 64, many are confident that some of California’s financial institutions will be taking advantage of FinCEN’s 2014 guidelines by opening accounts for cannabis-related businesses. Despite there being worries of potential U.S. Attorney General, Jeff Sessions, or newly-elected President, Donald Trump, ordering the nullification of the Cole Memo, Trump has often stated that he believes these matters should be left to individual states to decide upon, a point brought forward during a recent interview with Singlepoint CEO Greg Lambrecht (http://nnw.fm/7GTHh).
Singlepoint is a holding company for a number of companies, including SingleSeed, an organization focused on providing efficient payment processing services to cannabis dispensaries in the U.S. The company started offering these services several years ago and intends to leverage its position as a ‘first mover’ in the marketplace after this year’s multi-state legalization of recreational marijuana.
During his interview on MoneyTV, Lambrecht shared the fact that the company has recently acquired the attention of a number of dispensaries interested in its services. According to the CEO, the company is redesigning the SingleSeed website in anticipation of the verdict on whether or not it will be able to aid cannabis businesses with their payment solutions moving forward. The company’s website revamp is expected to allow dispensaries to sign up in order for them to use a legal text message marketing program which will enable them to better communicate with their audiences.
This move will allow SingleSeed to start planning for the future, giving clients a head start and making the company a serious ‘first mover’ compared to competitors in the space. Although nothing is set in stone as to whether or not new laws will be put in place regarding the payment processing around the cannabis industry, Lambrecht stated that he believes decisions will be made as early as the first quarter of the coming year.
For more information, visit the company’s website at www.Singlepoint.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
Medical Transcription Billing, Corp. (NASDAQ: MTBC) Ready for New Challenges on Health Insurance Market as Fate of Obamacare Uncertain
One of the biggest questions after President-elect Donald Trump is officially sworn in is what will happen with the controversial Affordable Care Act, also known as Obamacare – a law intended to make health insurance more affordable for medium and low-income Americans. Trump himself has often pledged to repeal and replace the law when he takes office, while his pick for Secretary of Health, Georgia Rep. Tom Price is a fierce opponent of the plan and sponsored a reconciliation bill last year designed to cut funding for the program. The bill, which was passed by both houses of Congress but was vetoed by President Barack Obama, would have eliminated cost-sharing subsidies, premium tax credits and federal funding for Medicaid, as well as ended tax penalties for people who failed to maintain health insurance.
Since an outright repeal of the health law would be unlikely without bipartisan agreement, analysts say (http://nnw.fm/H3Hpw) Republicans might opt for a reconciliation bill again, as this would not require a supermajority of at least 60 seats in the Senate to ensure smooth passage of a countermeasure. The big question, however, is what would the Trump administration replace Obamacare with? What would the new health insurance law look like, and what effects it would have? Although the new administration has outlined some principles for reform, it is yet uncertain how these would be enforced.
Trump spoke in favor of creating health savings accounts and giving the state more power to regulate health insurance and Medicaid. In turn, leading GOP members in both houses of Congress have similar suggestions, ranging from tax credits adjusted for age instead of income and household size as the current law provides, and giving the state more flexibility and responsibility in managing Medicaid. Most notably, Republicans suggest the state fund Medicaid with a lump sum instead of paying a percentage of expenses.
Even if these plans have not yet been outlined in great detail, they do have a few common features, such as the use of health savings accounts, the creation of high-risk insurance pools and selling health insurance across state lines. Health analysts say health savings accounts offer tax advantages for people with high-deductible health plans and can potentially be very beneficial for people with higher income. High-risk insurance pools would also be more beneficial for higher-earning people who don’t normally qualify for tax subsidies, but covering the sickest patients separately would indeed stabilize insurance premiums for everyone else who buys insurance on their own. And allowing health insurers to offer policies in another state than that of purchase would give buyers considerably more options, but concerns remain that insurers might choose to operate only in states that have the least consumer protection.
It remains to be seen what the new administration will bring and how it will affect everyone on the market, from doctors and patients to health insurance providers and other companies in the field, including healthcare IT service providers such as Medical Transcription Billing, Corp. (NASDAQ: MTBC) (NASDAQ: MTBCP). There are concerns that if the Trump administration completely repeals Obamacare, this might remove the need for a series of services currently offered by healthcare technology companies, such as revenue cycle management or more comprehensive practice management solutions.
Medical Transcription Billing believes the exact opposite. The company’s management feels that it is very unlikely that the Trump administration and the Republican-led Congress will completely eliminate insurance for 25 million Americans. The more likely scenario is that the administration will reduce subsidies and eliminate penalties for uninsured people. This, in turn, could lead to some healthy people dropping coverage and insurance companies getting even more strict on payouts, Medical Transcription Billing managers believe.
In this scenario, where doctors would have to fight insurance companies even harder for reimbursements, services such as the ones offered by MTBC will become more valuable than ever, the company’s management thinks. Medical Transcription Billing leverages proprietary technology and a global team of professionals to serve a wide range of healthcare customers, from individual physicians to medium-sized practices. It offers one of the most comprehensive suites of practice management, revenue cycle solutions and electronic health records on the market.
For more information, visit www.MTBC.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
Since an outright repeal of the health law would be unlikely without bipartisan agreement, analysts say (http://nnw.fm/H3Hpw) Republicans might opt for a reconciliation bill again, as this would not require a supermajority of at least 60 seats in the Senate to ensure smooth passage of a countermeasure. The big question, however, is what would the Trump administration replace Obamacare with? What would the new health insurance law look like, and what effects it would have? Although the new administration has outlined some principles for reform, it is yet uncertain how these would be enforced.
Trump spoke in favor of creating health savings accounts and giving the state more power to regulate health insurance and Medicaid. In turn, leading GOP members in both houses of Congress have similar suggestions, ranging from tax credits adjusted for age instead of income and household size as the current law provides, and giving the state more flexibility and responsibility in managing Medicaid. Most notably, Republicans suggest the state fund Medicaid with a lump sum instead of paying a percentage of expenses.
Even if these plans have not yet been outlined in great detail, they do have a few common features, such as the use of health savings accounts, the creation of high-risk insurance pools and selling health insurance across state lines. Health analysts say health savings accounts offer tax advantages for people with high-deductible health plans and can potentially be very beneficial for people with higher income. High-risk insurance pools would also be more beneficial for higher-earning people who don’t normally qualify for tax subsidies, but covering the sickest patients separately would indeed stabilize insurance premiums for everyone else who buys insurance on their own. And allowing health insurers to offer policies in another state than that of purchase would give buyers considerably more options, but concerns remain that insurers might choose to operate only in states that have the least consumer protection.
It remains to be seen what the new administration will bring and how it will affect everyone on the market, from doctors and patients to health insurance providers and other companies in the field, including healthcare IT service providers such as Medical Transcription Billing, Corp. (NASDAQ: MTBC) (NASDAQ: MTBCP). There are concerns that if the Trump administration completely repeals Obamacare, this might remove the need for a series of services currently offered by healthcare technology companies, such as revenue cycle management or more comprehensive practice management solutions.
Medical Transcription Billing believes the exact opposite. The company’s management feels that it is very unlikely that the Trump administration and the Republican-led Congress will completely eliminate insurance for 25 million Americans. The more likely scenario is that the administration will reduce subsidies and eliminate penalties for uninsured people. This, in turn, could lead to some healthy people dropping coverage and insurance companies getting even more strict on payouts, Medical Transcription Billing managers believe.
In this scenario, where doctors would have to fight insurance companies even harder for reimbursements, services such as the ones offered by MTBC will become more valuable than ever, the company’s management thinks. Medical Transcription Billing leverages proprietary technology and a global team of professionals to serve a wide range of healthcare customers, from individual physicians to medium-sized practices. It offers one of the most comprehensive suites of practice management, revenue cycle solutions and electronic health records on the market.
For more information, visit www.MTBC.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
SenesTech, Inc. (SNES) is “One to Watch”
With the recent EPA approval (http://nnw.fm/X82tJ) of SenesTech’s (NASDAQ: SNES) ContraPest®, a humane, liquid contraceptive bait designed to address unwieldy rodent populations, there now appears to be an impending end to the unsustainable rodenticide paradigm that has persisted for decades due to a lack of other options. SenesTech is Arizona’s newest public company, as of its December 8 IPO (http://nnw.fm/m4xhG) on the NASDAQ Capital Market. The publicly traded stock gives investors a big opportunity to get in on the ground floor behind a proprietary and potentially paradigm-shattering technology that is not only safe to humans, but also drastically less impactful to the environment.
The roughly $724 million global rodenticides market continues to grow at a healthy pace on the strength of demand from residential, municipal and agricultural consumers. Zion Market Research recently pegged (http://nnw.fm/eiU1t) the forward CAGR at around 5.6 percent through 2021, when the sector will likely break the billion dollar mark for the first time. One of the only two things slowing the rodenticides market down is the impact of these various poisons on the environment and the splash damage of their use to household pets and infants. This is a daunting industry concern which has, in part, helped fuel ever more stringent government regulations on the purchase and use of such poisons.
As SenesTech’s CEO, Dr. Loretta Mayer, explained during a spot on famed physicist Stephen Hawking’s show (http://nnw.fm/G5iuc): the poison paradigm itself is inherently flawed. The primary defect of the existing paradigm, identified by SenesTech, boils down to the fact that even if you manage to kill off all the rats in a given environment where they are able to flourish, more rats will just move in and reload the carrying capacity. Hence the ingeniousness of SenesTech’s ContraPest, the first ever rodent fertility control product approved by the FDA and EPA alike, whose active ingredients pose no threat to human reproductive activity and metabolize quickly (under 15 minutes) in rodents. This means that if a family pet eats a dosed rodent, there is no risk it will suffer reproductive impairment. The primary synthetic active ingredient in ContraPest, VCD (4-vinylcyclohexene diepoxide) (http://nnw.fm/Xvf8l), has been used for decades in manufacturing soaps and cosmetics without toxicity to humans being an issue, and it also breaks down rapidly in water, meaning there is no risk of environmental accumulation.
By acting to chemically speed up the natural rate at which eggs deplete in females (resulting in early menopause), as well as inducing follicle (primordial and primary) depletion and testis disruption in males (both in a highly targeted fashion), ContraPest is able to achieve sterilization without systemic toxicity or adverse side effects. This is a key advantage which makes ContraPest an extremely attractive, non-lethal option.
This product has a completely different profile than rodenticides containing ingredients like bromadiolone and brodifacoum, which are hugely toxic. In fact, they are as much as 200 times more toxic than more typical warfarin and hydroxycoumadin based products. A non-lethal chemical sterilizer that won’t do splash damage or accumulate is a very interesting vector for controlling a whole host of populations. Indeed, the potential exists with SenesTech’s technology to similarly address a wide variety of other mammalian pests (like gophers, moles, skunks, and voles) using uniquely formulated versions of the non-lethal solution. And the technology could even evolve into a humane vector for curbing out-of-control companion animal populations, as well as animals like wild deer or hogs.
Think about it. We have been using poisons at sizeable volumes for decades to curb rat populations, especially in large cities like NYC, and we still have enormous, increasingly unaddressable rodent control problems on our hands. Despite shelling out around $3 million last year to fight the furry invaders (http://nnw.fm/2UmQ8), the rat population in NYC ballooned north of 2 million. The city saw a high of 15,272 complaints in 2015, a nearly 45 percent increase (http://nnw.fm/Nns1m) over the last five years. Council Member Inez Dickens was quoted earlier this year as saying that one cannot even sit in Central Park sometimes because the rat problem is so bad. One of the main underlying logistical issues is the abundance of literal rat reservoirs in parks, sewers and subways where teeming rat populations continue to thwart all attempts at effective management using standard practices.
For just one example site in NYC, pest control personnel put down tens of traps and hundreds of pounds of poison over a period of three months, with negligible improvements to the rat population. This kind of case history underscores the sheer futility in certain cases of attempting to address the problem using existing poisoning methods. Moreover, when used in homes, rat poisons are a significant danger to both children and pets. There are more than 10,000 children exposed to rat poison each year (http://nnw.fm/p5NJp) and nearly all of them are under three years of age.
Rats are quite intelligent and actually learn to avoid traps too. Thus, as long as a ready food supply of some kind exists in proximity, rodents are much less likely to eat what is typically powdered poison, or mess around with anything that even looks like a trap. Here is another typical use area where ContraPest can really shine, in that the product is formulated in two yummy flavors. A super-sweet condensed milk-like liquid and a semi-soft bait that is the consistency of cream cheese. Both flavor/texture profiles were chosen by SenesTech because they have been shown to be highly appetizing to rats. There are diminishing returns built right into the economics of poisoning rats and this little company could potentially flip the script on a soon-to-be billion dollar global rodenticides market.
SenesTech’s approach to the management of rodent populations makes perfect sense. Rats reach sexual maturity in only eight to 12 weeks and can have a staggering six or more litters per year. This means that a single female can, over the course of only nine months, give rise to some 1.75 million descendants.
We have been hacking at the branches for decades – but with the advent of the SenesTech IPO, investors have gained access to a potential superstar that is striking directly at the root in a market that is not yet fully understood. And SNES is striking with a specially formulated solution that was clever enough to previously land a $1.1 million grant from the NIH to pursue more comprehensive field trials. It’s important to note that SNES didn’t just build a better mousetrap. The company has successfully engineered a product that gets rid of the need for mousetraps in the first place. No more fishing for slain rats in the HVAC system that are producing some unidentifiable smell, and no more paying for exterminators at hundreds if not thousands of dollars a pop. Things look good for this young disruptor, and with the exposure a NASDAQ listing brings, SenesTech could have the kind of financial leeway needed to really take things to the next level.
It’s no wonder the company did a big management restructure back in January (http://nnw.fm/D5e1z), the crystallizing force behind its already impressive momentum. Key additions were made, such as a former president and CEO of a Roche Group member company, as well as a founder of the well-known alfalfa and stevia-focused proprietary seed company, S&W Seed (NASDAQ: SANW). Dr. Mayer reasserted her control as CEO and board chair at that same time, as well as dropping the dime on the company’s emerging global commercialization partnerships that could see ContraPest tap directly into the broader international rodenticide space.
To take a closer look, visit www.SenesTech.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
The roughly $724 million global rodenticides market continues to grow at a healthy pace on the strength of demand from residential, municipal and agricultural consumers. Zion Market Research recently pegged (http://nnw.fm/eiU1t) the forward CAGR at around 5.6 percent through 2021, when the sector will likely break the billion dollar mark for the first time. One of the only two things slowing the rodenticides market down is the impact of these various poisons on the environment and the splash damage of their use to household pets and infants. This is a daunting industry concern which has, in part, helped fuel ever more stringent government regulations on the purchase and use of such poisons.
As SenesTech’s CEO, Dr. Loretta Mayer, explained during a spot on famed physicist Stephen Hawking’s show (http://nnw.fm/G5iuc): the poison paradigm itself is inherently flawed. The primary defect of the existing paradigm, identified by SenesTech, boils down to the fact that even if you manage to kill off all the rats in a given environment where they are able to flourish, more rats will just move in and reload the carrying capacity. Hence the ingeniousness of SenesTech’s ContraPest, the first ever rodent fertility control product approved by the FDA and EPA alike, whose active ingredients pose no threat to human reproductive activity and metabolize quickly (under 15 minutes) in rodents. This means that if a family pet eats a dosed rodent, there is no risk it will suffer reproductive impairment. The primary synthetic active ingredient in ContraPest, VCD (4-vinylcyclohexene diepoxide) (http://nnw.fm/Xvf8l), has been used for decades in manufacturing soaps and cosmetics without toxicity to humans being an issue, and it also breaks down rapidly in water, meaning there is no risk of environmental accumulation.
By acting to chemically speed up the natural rate at which eggs deplete in females (resulting in early menopause), as well as inducing follicle (primordial and primary) depletion and testis disruption in males (both in a highly targeted fashion), ContraPest is able to achieve sterilization without systemic toxicity or adverse side effects. This is a key advantage which makes ContraPest an extremely attractive, non-lethal option.
This product has a completely different profile than rodenticides containing ingredients like bromadiolone and brodifacoum, which are hugely toxic. In fact, they are as much as 200 times more toxic than more typical warfarin and hydroxycoumadin based products. A non-lethal chemical sterilizer that won’t do splash damage or accumulate is a very interesting vector for controlling a whole host of populations. Indeed, the potential exists with SenesTech’s technology to similarly address a wide variety of other mammalian pests (like gophers, moles, skunks, and voles) using uniquely formulated versions of the non-lethal solution. And the technology could even evolve into a humane vector for curbing out-of-control companion animal populations, as well as animals like wild deer or hogs.
Think about it. We have been using poisons at sizeable volumes for decades to curb rat populations, especially in large cities like NYC, and we still have enormous, increasingly unaddressable rodent control problems on our hands. Despite shelling out around $3 million last year to fight the furry invaders (http://nnw.fm/2UmQ8), the rat population in NYC ballooned north of 2 million. The city saw a high of 15,272 complaints in 2015, a nearly 45 percent increase (http://nnw.fm/Nns1m) over the last five years. Council Member Inez Dickens was quoted earlier this year as saying that one cannot even sit in Central Park sometimes because the rat problem is so bad. One of the main underlying logistical issues is the abundance of literal rat reservoirs in parks, sewers and subways where teeming rat populations continue to thwart all attempts at effective management using standard practices.
For just one example site in NYC, pest control personnel put down tens of traps and hundreds of pounds of poison over a period of three months, with negligible improvements to the rat population. This kind of case history underscores the sheer futility in certain cases of attempting to address the problem using existing poisoning methods. Moreover, when used in homes, rat poisons are a significant danger to both children and pets. There are more than 10,000 children exposed to rat poison each year (http://nnw.fm/p5NJp) and nearly all of them are under three years of age.
Rats are quite intelligent and actually learn to avoid traps too. Thus, as long as a ready food supply of some kind exists in proximity, rodents are much less likely to eat what is typically powdered poison, or mess around with anything that even looks like a trap. Here is another typical use area where ContraPest can really shine, in that the product is formulated in two yummy flavors. A super-sweet condensed milk-like liquid and a semi-soft bait that is the consistency of cream cheese. Both flavor/texture profiles were chosen by SenesTech because they have been shown to be highly appetizing to rats. There are diminishing returns built right into the economics of poisoning rats and this little company could potentially flip the script on a soon-to-be billion dollar global rodenticides market.
SenesTech’s approach to the management of rodent populations makes perfect sense. Rats reach sexual maturity in only eight to 12 weeks and can have a staggering six or more litters per year. This means that a single female can, over the course of only nine months, give rise to some 1.75 million descendants.
We have been hacking at the branches for decades – but with the advent of the SenesTech IPO, investors have gained access to a potential superstar that is striking directly at the root in a market that is not yet fully understood. And SNES is striking with a specially formulated solution that was clever enough to previously land a $1.1 million grant from the NIH to pursue more comprehensive field trials. It’s important to note that SNES didn’t just build a better mousetrap. The company has successfully engineered a product that gets rid of the need for mousetraps in the first place. No more fishing for slain rats in the HVAC system that are producing some unidentifiable smell, and no more paying for exterminators at hundreds if not thousands of dollars a pop. Things look good for this young disruptor, and with the exposure a NASDAQ listing brings, SenesTech could have the kind of financial leeway needed to really take things to the next level.
It’s no wonder the company did a big management restructure back in January (http://nnw.fm/D5e1z), the crystallizing force behind its already impressive momentum. Key additions were made, such as a former president and CEO of a Roche Group member company, as well as a founder of the well-known alfalfa and stevia-focused proprietary seed company, S&W Seed (NASDAQ: SANW). Dr. Mayer reasserted her control as CEO and board chair at that same time, as well as dropping the dime on the company’s emerging global commercialization partnerships that could see ContraPest tap directly into the broader international rodenticide space.
To take a closer look, visit www.SenesTech.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
Subscribe to:
Posts (Atom)